• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomas.

作者信息

Wick Wolfgang, Winkler Frank

机构信息

Neurology Clinic, University of Heidelberg; Clinical Cooperation Unit Neurooncology, German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany.

出版信息

Cancer. 2018 Jul 1;124(13):2674-2676. doi: 10.1002/cncr.31371. Epub 2018 Apr 26.

DOI:10.1002/cncr.31371
PMID:29698549
Abstract
摘要

相似文献

1
Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomas.丙卡巴肼、洛莫司汀和长春新碱方案与替莫唑胺治疗胶质瘤的对比
Cancer. 2018 Jul 1;124(13):2674-2676. doi: 10.1002/cncr.31371. Epub 2018 Apr 26.
2
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.NOA-04 间变性胶质瘤序贯放化疗（采用丙卡巴肼、洛莫司汀和长春新碱或替莫唑胺）的随机 III 期试验
J Clin Oncol. 2009 Dec 10;27(35):5874-80. doi: 10.1200/JCO.2009.23.6497. Epub 2009 Nov 9.
3
Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected].间变性胶质瘤：如何预测预后及选择治疗策略。[已校正]
J Clin Oncol. 2009 Dec 10;27(35):5861-2. doi: 10.1200/JCO.2009.24.5985. Epub 2009 Nov 9.
4
MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.O6-甲基鸟嘌呤-DNA甲基转移酶（MGMT）启动子甲基化对间变性少突胶质细胞瘤辅助PCV化疗的预后有影响，但无预测作用：欧洲癌症研究与治疗组织（EORTC）脑肿瘤组26951研究报告
J Clin Oncol. 2009 Dec 10;27(35):5881-6. doi: 10.1200/JCO.2009.24.1034. Epub 2009 Nov 9.
5
Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.高危低级别胶质瘤的放化疗：替莫唑胺与 PCV 的选择。
Cancer Med. 2020 Jan;9(1):3-11. doi: 10.1002/cam4.2686. Epub 2019 Nov 7.
6
Procarbazine, lomustine and vincristine for recurrent high-grade glioma.丙卡巴肼、洛莫司汀和长春新碱用于复发性高级别胶质瘤。
Cochrane Database Syst Rev. 2017 Jul 26;7(7):CD011773. doi: 10.1002/14651858.CD011773.pub2.
7
Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.替莫唑胺对比洛莫司汀、司莫司汀和长春新碱治疗复发性高级别胶质瘤。
J Clin Oncol. 2010 Oct 20;28(30):4601-8. doi: 10.1200/JCO.2009.27.1932. Epub 2010 Sep 20.
8
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.NRG 肿瘤学/RTOG9802 中的全面基因组分析：一项 III 期试验，比较放疗与放疗加洛莫司汀、司莫司汀（CCNU）和长春新碱治疗高危低级别胶质瘤。
J Clin Oncol. 2020 Oct 10;38(29):3407-3417. doi: 10.1200/JCO.19.02983. Epub 2020 Jul 24.
9
[Clinicopathological diagnosis of gliomas by genotype analysis].[通过基因分型分析对胶质瘤进行临床病理诊断]
Brain Nerve. 2009 Jul;61(7):773-80.
10
Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for temozolomide.治疗间变性少突胶质细胞瘤和世界卫生组织2级胶质瘤：PCV方案还是替莫唑胺？替莫唑胺的情况
Oncology (Williston Park). 2015 Apr;29(4):265, 275.

引用本文的文献

1
Survival Analysis and Correlates with Molecular Epidemiology: 10-Year Retrospective Series of High-Grade Glioma in Pakistan.生存分析及其与分子流行病学的关联：巴基斯坦高级别胶质瘤的10年回顾性系列研究
J Cancer Allied Spec. 2024 Jan 22;10(1):565. doi: 10.37029/jcas.v10i1.565. eCollection 2024.
2
4-Methylumbelliferone enhances the effects of chemotherapy on both temozolomide-sensitive and resistant glioblastoma cells.4-甲基伞形酮增强了替莫唑胺敏感和耐药胶质母细胞瘤细胞对化疗的作用。
Sci Rep. 2023 Jun 8;13(1):9356. doi: 10.1038/s41598-023-35045-3.
3
Therapeutic Options in Neuro-Oncology.
神经肿瘤学的治疗选择。
Int J Mol Sci. 2022 May 11;23(10):5351. doi: 10.3390/ijms23105351.
4
Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells.衰老 是 替莫唑胺 在 胶质母细胞瘤 细胞 中 诱导产生 的 主要 特征。
Cancers (Basel). 2022 Apr 29;14(9):2233. doi: 10.3390/cancers14092233.
5
Clinical feasibility of modified procarbazine and lomustine chemotherapy without vincristine as a salvage treatment for recurrent adult glioma.改良丙卡巴肼和洛莫司汀化疗（不含长春新碱）作为复发性成人胶质瘤挽救治疗的临床可行性
Oncol Lett. 2022 Apr;23(4):114. doi: 10.3892/ol.2022.13234. Epub 2022 Feb 9.
6
Accumulation of Temozolomide-Induced Apoptosis, Senescence and DNA Damage by Metronomic Dose Schedule: A Proof-of-Principle Study with Glioblastoma Cells.替莫唑胺诱导的细胞凋亡、衰老和DNA损伤通过节拍给药方案的累积：一项针对胶质母细胞瘤细胞的原理验证研究
Cancers (Basel). 2021 Dec 14;13(24):6287. doi: 10.3390/cancers13246287.
7
Molecular Dosimetry of Temozolomide: Quantification of Critical Lesions, Correlation to Cell Death Responses, and Threshold Doses.替莫唑胺的分子剂量学：关键损伤的定量、与细胞死亡反应的相关性和阈剂量。
Mol Cancer Ther. 2021 Oct;20(10):1789-1799. doi: 10.1158/1535-7163.MCT-21-0228. Epub 2021 Jul 12.
8
Nanogels as a Versatile Drug Delivery System for Brain Cancer.纳米凝胶作为一种用于脑癌的多功能药物递送系统。
Gels. 2021 May 26;7(2):63. doi: 10.3390/gels7020063.
9
Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas.高级别神经胶质瘤的标准治疗和药物研发的挑战与展望。
Molecules. 2021 Feb 22;26(4):1169. doi: 10.3390/molecules26041169.
10
Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?替莫唑胺诱导胶质母细胞瘤细胞死亡反应是否存在阈值？
Int J Mol Sci. 2019 Mar 28;20(7):1562. doi: 10.3390/ijms20071562.